This new FDA-approved shot is designed to break down the barriers that have kept too many people from accessing PrEP.

Merck MRK announced that the FDA has accepted for review the new drug application (“NDA”) seeking approval for its ...

Government should increase their allocation to the health sector to at least 15 percent of the total National Budget ...

A journey through the FDA’s newly released complete response letters gave glimpses into the journeys to market for Eli ...

Gilada, the only Indian serving on the International AIDS Society (IAS) Governing Council, assured the country has the ...

Amarna Therapeutics and NorthX Biologics finalized an agreement to advance Nimvec AM510 gene therapy toward clinical trials for Type 1 Diabetes. Now in its fourth year, the MM+M Media Summit brings ...

A twice-yearly injection could help Australia eliminate HIV, but experts are sounding the alarm over its prohibitive cost.

About 17,000 people are set to benefit from free access to the long-acting HIV prevention injection, lenacapavir, which only needs to be administered twice a year. This follows a new ...

Trump administration funding cuts and dismantling of USAID force a shift from HIV elimination back to treatment.

Funding cuts to the global HIV response could trigger a surge of 6 million new infections and 4 million AIDS-related ...

Global progress against AIDS is at risk as US funding cuts threaten life-saving programs. Experts warn of millions of ...

Only 17,000 Ugandans to benefit from $1.1m Global Fund support as officials warn of high demand for long-acting prevention ...